InflaRx
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell InflaRx and other ETFs, options, and stocks.About IFRX
InflaRx NV is a clinical-stage biopharmaceutical company, which engages in the discovery and development of inhibitors of the complement activation factor known as C5a and its receptor C5aR. Its primary product candidate is Vilobelimab.
CEONiels Christoph Riedemann
CEONiels Christoph Riedemann
Employees74
Employees74
HeadquartersJena, Thueringen
HeadquartersJena, Thueringen
Founded2007
Founded2007
Employees74
Employees74
IFRX Key Statistics
Market cap57.15M
Market cap57.15M
Price-Earnings ratio-0.78
Price-Earnings ratio-0.78
Dividend yield—
Dividend yield—
Average volume548.55K
Average volume548.55K
High today$0.8929
High today$0.8929
Low today$0.80
Low today$0.80
Open price$0.8652
Open price$0.8652
Volume405.97K
Volume405.97K
52 Week high$2.82
52 Week high$2.82
52 Week low$0.7113
52 Week low$0.7113
IFRX News
TipRanks 1d
InflaRx Receives Nasdaq Deficiency Notice for Share PriceElevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to...
Simply Wall St 6d
Is InflaRx In A Good Position To Deliver On Growth Plans?Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the right price. For example, although softwar...
Analyst ratings
86%
of 7 ratingsBuy
85.7%
Hold
14.3%
Sell
0%
People also own
Based on the portfolios of people who own IFRX. This list is generated using Robinhood data, and it’s not a recommendation.